Dissemin is shutting down on January 1st, 2025

Published in

Springer, Clinical and Translational Oncology, 2(22), p. 171-186, 2020

DOI: 10.1007/s12094-019-02263-z

Links

Tools

Export citation

Search in Google Scholar

SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)

Journal article published in 2020 by A. J. Muñoz Martín ORCID, E. Gallardo Díaz ORCID, I. García Escobar, R. Macías Montero, V. Martínez-Marín, V. Pachón Olmos, P. Pérez Segura, T. Quintanar Verdúguez, M. Salgado Fernández
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

AbstractIn 2011, the Spanish Society of Medical Oncology (SEOM) first published a clinical guideline of venous thromboembolism (VTE) and cancer. This guideline was updated in 2014, and since then, multiple studies and clinical trials have changed the landscape of the treatment and prophylaxis of VTE in cancer patients. To incorporate the most recent evidence, including data from direct oral anticoagulants (DOACs) randomized clinical trials, SEOM presents a new update of the guideline.